These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 11200799)

  • 1. The search for novel migraine therapies: experimental models.
    Parsons AA; Bingham S
    Funct Neurol; 2000; 15 Suppl 3():36-42. PubMed ID: 11200799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Role of serotonin and other neuroactive molecules in the physiopathogenesis of migraine. Current hypotheses].
    Hamon M; Bourgoin S
    Pathol Biol (Paris); 2000 Sep; 48(7):619-29. PubMed ID: 11072640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New migraine and pain research.
    Hargreaves R
    Headache; 2007 Apr; 47 Suppl 1():S26-43. PubMed ID: 17425708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An introduction to migraine: from ancient treatment to functional pharmacology and antimigraine therapy.
    Villalón CM; Centurión D; Valdivia LF; De Vries P; Saxena PR
    Proc West Pharmacol Soc; 2002; 45():199-210. PubMed ID: 12434581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental migraine models and their relevance in migraine therapy.
    Arulmani U; Gupta S; VanDenBrink AM; Centurión D; Villalón CM; Saxena PR
    Cephalalgia; 2006 Jun; 26(6):642-59. PubMed ID: 16686903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The discovery of a new drug class for the acute treatment of migraine.
    Humphrey PP
    Headache; 2007 Apr; 47 Suppl 1():S10-9. PubMed ID: 17425704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotonin receptors and the acute attack of migraine.
    Goadsby PJ
    Clin Neurosci; 1998; 5(1):18-23. PubMed ID: 9523053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analgesic triptan action in an animal model of intracranial pain: a race against the development of central sensitization.
    Burstein R; Jakubowski M
    Ann Neurol; 2004 Jan; 55(1):27-36. PubMed ID: 14705109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Triptans--pivotal event in migraine treatment].
    Lusić I; Bilić I
    Acta Med Croatica; 2008 May; 62(2):173-8. PubMed ID: 18710081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Physiopathology of the migraine crisis and its treatment with a 5-HT1-like agonist].
    Arch Neurobiol (Madr); 1989; 52(5):254-6. PubMed ID: 2559670
    [No Abstract]   [Full Text] [Related]  

  • 11. Zelrix: a novel transdermal formulation of sumatriptan.
    Pierce M; Marbury T; O'Neill C; Siegel S; Du W; Sebree T
    Headache; 2009 Jun; 49(6):817-25. PubMed ID: 19438727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sumatriptan and naproxen sodium for the acute treatment of migraine.
    Smith TR; Sunshine A; Stark SR; Littlefield DE; Spruill SE; Alexander WJ
    Headache; 2005 Sep; 45(8):983-91. PubMed ID: 16109111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatments of migraine].
    Lucas C; Valade D
    Rev Prat; 2008 Mar; 58(6):625-37. PubMed ID: 18437951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current concepts of migraine pathophysiology.
    Hamel E
    Can J Clin Pharmacol; 1999; 6 Suppl A():9A-14A. PubMed ID: 10494006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Future pharmacologic targets for acute and preventive treatments of migraine.
    Buchanan TM; Ramadan NM; Aurora S
    Expert Rev Neurother; 2004 May; 4(3):391-430. PubMed ID: 15853537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Migraine: current concepts and emerging therapies.
    Arulmozhi DK; Veeranjaneyulu A; Bodhankar SL
    Vascul Pharmacol; 2005 Sep; 43(3):176-87. PubMed ID: 16099727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Animal models of migraine: looking at the component parts of a complex disorder.
    Bergerot A; Holland PR; Akerman S; Bartsch T; Ahn AH; MaassenVanDenBrink A; Reuter U; Tassorelli C; Schoenen J; Mitsikostas DD; van den Maagdenberg AM; Goadsby PJ
    Eur J Neurosci; 2006 Sep; 24(6):1517-34. PubMed ID: 17004916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacology and efficacy of eletriptan for the treatment of migraine attacks.
    Diener HC; McHarg A
    Int J Clin Pract; 2000 Dec; 54(10):670-4. PubMed ID: 11221281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Migraine in the triptan era: lessons from epidemiology, pathophysiology, and clinical science.
    Bigal ME; Ferrari M; Silberstein SD; Lipton RB; Goadsby PJ
    Headache; 2009 Feb; 49 Suppl 1():S21-33. PubMed ID: 19161562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Terminating migraine with allodynia and ongoing central sensitization using parenteral administration of COX1/COX2 inhibitors.
    Jakubowski M; Levy D; Goor-Aryeh I; Collins B; Bajwa Z; Burstein R
    Headache; 2005; 45(7):850-61. PubMed ID: 15985101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.